Cancer Medicine (Jun 2020)

Chemokines and chemokine receptors: A new strategy for breast cancer therapy

  • Hui Liu,
  • Zhenjiang Yang,
  • Wenping Lu,
  • Zhen Chen,
  • Lianyu Chen,
  • Shuyan Han,
  • Xiaoyu Wu,
  • Tiange Cai,
  • Yu Cai

DOI
https://doi.org/10.1002/cam4.3014
Journal volume & issue
Vol. 9, no. 11
pp. 3786 – 3799

Abstract

Read online

Abstract Chemokines and chemokine receptors not only participate in the development of tissue differentiation, hematopoiesis, inflammation, and immune regulation but also play an important role in the process of tumor development. The role of chemokines and chemokine receptors in tumors has been emphasized in recent years. More and more studies have shown that chemokines and chemokine receptors are closely related to the occurrence, angiogenesis, metastasis, drug resistance, and immunity of breast cancer. Here, we review recent progression on the roles of chemokines and chemokine receptors in breast cancer, and discuss the possible mechanism in breast cancer that might facilitate the development of new therapies by targeting chemokines as well as chemokine receptors. Chemokines and chemokine receptors play an important role in the occurrence and development of breast cancer. In‐depth study of chemokines and chemokine receptors can provide intervention targets for breast cancer biotherapy. The regulation of chemokines and chemokine receptors may become a new strategy for breast cancer therapy.

Keywords